-
-
[1]Hilleman MR.Overview of the pathogenesis, prophylaxis and thera-peusis of viral hepatitis B, with focus on reduction to practical appli-cations[J].Vaccine, 2001, 19∶1837-1848. [2]梁晓峰, 陈园生, 王晓军, 等.中国3岁以上人群乙型肝炎血清流行病学研究[J].中华流行病学杂志, 2005, 26∶655-658. [3]Lok AS, McMahon BJ.Chronic hepatitis B[J].Hepatology, 2001, 34∶1225-1241. [4]Gabrilovich DI, Patterson S, Harvey JJ, et al.Defects in the func-tion of dendrentic cells in murine retroviral infection[J].Adv ExpMed Biol, 1995, 378∶469-472. [5]Maria-christina J.Gerd RP.Immunology of hepatitis Binfection[J].Lancet infectious Diseases, 2001, 2∶43-50. [6]Kazuhiro K, Luca GG, Yasuhiko K, et al.Natural killer Tcell acti-vation inhibits hepatitis B virus replication in vivo[J].J Exp Med, 2000, 192 (7) ∶921-930. [7]Marin AR, Ruiz S, Parrillas V, et al.Origin and differentiation ofdendritic cells[J].Trends Immund, 2001, 22∶691-700. [8]Banchereau J, Steinment RM.Dendritic cells and the control of im-munity[J].nature, 1998, 392 (6673) ∶245-252. [9]Gomez J, Borras FE, Singh R, et al.Differential up-regulation ofHLA-DM, in varint chain, and CD83 on myeloid and plasmacytoiddendritic cells from peripheral blood[J].Tissue Antigens, 2004, 63 (2) ∶149-157. [10]Liu YJ.Dendritic cells subsets and lineagesand their functions ininnate and adaptive immunity[J].Cell, 2001, 106∶259-262. [11]Van der Molen RG, Spreagers D, Birda RS, et al.Functional im-pairmentin of myeloid and plasmacytiod dendritic cells of patientswith chronic hepatitis B[J].Hepatology, 2004, 40 (3) ∶738-746. [12]李若冰, 陈红松, 费然, 等.慢性乙型肝炎患者外周血树突细胞功能的研究[J].中华医学杂志, 2002, 82 (13) ∶887-890. [13]于建武, 王富贵, 吕淑兰.慢性乙型肝炎患者外周血树突细胞功能的研究[J].中华传染病志, 2001, 19 (3) ∶144-147. [14]Lohr HF, Pingel S, Bocher WO, et al.Reduced virus specific Thelper cell induction by autologous dendritic cells in patients withchronic hepatitis B-restoration by exogenous interleution-12[J].Clin Exp Immunol, 2002, 130∶107-114. [15]刘树人, 张雁.慢性乙型肝炎患者树突状细胞形态、表型和功能的变化[J].细胞与分子免疫学杂志, 2001, 17 (5) ∶437-439. [16]Tavakoli S, Schwerin W, Rohwer A, et al.Phenotype and functionof monocyte derived dendritic cells in chronic hepatitis B virus infec-tion[J].J Gen Virol, 2004, 85∶2829-2836. [17]Beckebaum S, Cicinnavi VR, Zhang x, et al.Hepatitis B virus-induced defect of monocyte-derived dendritic cells leads to impairedThelper type-1 respons in vitro:mechanisms for viral immune es-cape[J].Immunology, 2003, 109∶487-495. [18]Horrike N, Onji M.The role of dysfunction of dendritic cells inhepatitis B virus persistent infection[J].Nippon Rinsho, 2004, 62Suppl 8∶70-73. [19]Kunitani H, Shimizu Y, Murata H, et al.Phenotypic analysis ofcirculating and intrahepatic dendritic cell subsets in patients withshronic liver diseases[J].J Hepatol, 2002, 36∶734-741. [20]Chisari FV, Ferrari C.Hepatitis B virus immunopathogenesis[J].Annu Rev Immunol, 1995, 13∶29-60. [21]Trippler M, Meyer zum Buschenfelde KH.HBV viral load withinsubpopulations of peripheral blood mononuclear cells in HBV infec-tion using limiting dilution PCR[J].J Virol methods, 1999, 78 (1-2) ∶129-147. [22]Munz C, Steinman RM, Fujii S.Dendritic cell maturation by innatelymphocytes:coordinated stimulation of innate and adaptiveimmunity[J].J Exp Med, 2005, 202∶203-207. [23]Akbar SM, Masumoto T.Mechanism of action of vaccine therapy inmurine hepatitis B virus carriers:vaccine induced activation of anti-gen presenting dendritic cells[J].J Hepatol, 1999, 30∶755-764. [24]Morikazu Onji.Dendritic cells in clinics[M].Tokyo, Japan:Springer, 2004∶9-40. [25]Horiike N, Akbar SMF, Ninomiya T, et al.Activition and matura-tion of antigen-presenting dendritic cells during vaccine therapy inpatients with chronic hepatitis due to hepatitis B virus[J].HepatolRes, 2002, 23∶38-47. [26]刑利和, 马文平, 王友臣, 等.HBsAg致敏的树突状细胞体外抗乙型肝炎病毒的效应[J].解放军医学杂志, 2007, 32∶39-42. [27]Oka Y, Akbar SM, Horiike N, et al.Mechanism and therapeuticpotential of DNA-based immunization against the envelope proteinsof hepatitis B virus in normal and transgenic mice[J].Immunology, 2001, 103∶90-97.
本文二维码
计量
- 文章访问数: 2074
- HTML全文浏览量: 12
- PDF下载量: 1086
- 被引次数: 0